All posts tagged
Ablynx Launches $150M IPO on Wall Street After Phase III Success
Belgian Biotech Breaks New Ground in Fight Against Life-Threatening Blood Disorder
Sanofi Offers up to €2.4Bn to Belgian Biotech to Develop Nanobodies
More News! Roche’s Stellar Hemophilia A Treatment & Two Big Rounds for Arix
Merck to Pay Ablynx €15M for Getting a Second Nanobody ready for the Clinic
Merck Outsources the Development of its Nanobody for Psoriasis
What are the Best Countries to Recruit Biotech Talents in 2017?
More News! Merck KGaA to drop Biosimilars? Sanofi buys into RSV
More News! Cevec moves into Zika, Ablynx’s Latest MAA, EMA in CPH?
Llama-inspired Nanobody Therapy for Psoriasis clears Phase I
An Antibody to reduce Hospitalizations of Children starts Phase IIb trials
UPDATE: The 5 Hottest European Biotechs in 2017 according to JP Morgan
Labiotech UG, All Rights Reserved -
Send this to a friend